These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 21896479)
1. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin. Veillard F; Saidi A; Burden RE; Scott CJ; Gillet L; Lecaille F; Lalmanach G J Biol Chem; 2011 Oct; 286(43):37158-67. PubMed ID: 21896479 [TBL] [Abstract][Full Text] [Related]
2. Genotyping and functional analysis of the D104N variant of human endostatin. Macpherson GR; Singh AS; Bennett CL; Venzon DJ; Liewehr DJ; Franks ME; Dahut WL; Kantoff PW; Price DK; Figg WD Cancer Biol Ther; 2004 Dec; 3(12):1298-303. PubMed ID: 15662127 [TBL] [Abstract][Full Text] [Related]
3. Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth. Yokoyama Y; Ramakrishnan S Cancer; 2005 Jul; 104(2):321-31. PubMed ID: 15952188 [TBL] [Abstract][Full Text] [Related]
4. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618 [TBL] [Abstract][Full Text] [Related]
5. Generation of endostatin by matrix metalloproteinase and cathepsin from human limbocorneal epithelial cells cultivated on amniotic membrane. Ma DH; Yao JY; Kuo MT; See LC; Lin KY; Chen SC; Chen JK; Chao AS; Wang SF; Lin KK Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):644-51. PubMed ID: 17251461 [TBL] [Abstract][Full Text] [Related]
6. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. Wang B; Sun J; Kitamoto S; Yang M; Grubb A; Chapman HA; Kalluri R; Shi GP J Biol Chem; 2006 Mar; 281(9):6020-9. PubMed ID: 16365041 [TBL] [Abstract][Full Text] [Related]
7. Generation and degradation of human endostatin proteins by various proteinases. Ferreras M; Felbor U; Lenhard T; Olsen BR; Delaissé J FEBS Lett; 2000 Dec; 486(3):247-51. PubMed ID: 11119712 [TBL] [Abstract][Full Text] [Related]
8. Opposite effects of endostatin on different endothelial cells. Schmidt A; Addicks K; Bloch W Cancer Biol Ther; 2004 Nov; 3(11):1162-6; discussion 1167-8. PubMed ID: 15640622 [TBL] [Abstract][Full Text] [Related]
9. Collagen XVIII/endostatin structure and functional role in angiogenesis. Zatterstrom UK; Felbor U; Fukai N; Olsen BR Cell Struct Funct; 2000 Apr; 25(2):97-101. PubMed ID: 10885579 [TBL] [Abstract][Full Text] [Related]
10. Secreted cathepsin L generates endostatin from collagen XVIII. Felbor U; Dreier L; Bryant RA; Ploegh HL; Olsen BR; Mothes W EMBO J; 2000 Mar; 19(6):1187-94. PubMed ID: 10716919 [TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization. Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141 [TBL] [Abstract][Full Text] [Related]
12. Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells. Mishima Y; Terui Y; Sugimura N; Matsumoto-Mishima Y; Rokudai A; Kuniyoshi R; Hatake K Cancer Sci; 2007 Mar; 98(3):364-72. PubMed ID: 17270026 [TBL] [Abstract][Full Text] [Related]
13. Expression of collagen XVIII mRNA and protein in human umbilical vein and placenta. Nasu K; Fujisawa K; Nishida Y; Kai S; Sugano T; Miyakawa I; Tateishi Y Reprod Fertil Dev; 2003; 15(1-2):107-14. PubMed ID: 12895407 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia down-regulates endostatin production by human microvascular endothelial cells and pericytes. Wu P; Yonekura H; Li H; Nozaki I; Tomono Y; Naito I; Ninomiya Y; Yamamoto H Biochem Biophys Res Commun; 2001 Nov; 288(5):1149-54. PubMed ID: 11700031 [TBL] [Abstract][Full Text] [Related]
15. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice. Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947 [TBL] [Abstract][Full Text] [Related]
17. Insights into differential endostatin activity. Maclachlan TK; Dhanabal M Cancer Biol Ther; 2004 Nov; 3(11):1167-8. PubMed ID: 15640617 [No Abstract] [Full Text] [Related]
18. Mechanical factors influence the expression of endostatin--an inhibitor of angiogenesis--in tendons. Pufe T; Petersen W; Kurz B; Tsokos M; Tillmann B; Mentlein R J Orthop Res; 2003 Jul; 21(4):610-6. PubMed ID: 12798059 [TBL] [Abstract][Full Text] [Related]
19. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814 [TBL] [Abstract][Full Text] [Related]
20. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo. Cattaneo MG; Pola S; Francescato P; Chillemi F; Vicentini LM Exp Cell Res; 2003 Feb; 283(2):230-6. PubMed ID: 12581742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]